Global phototherapy Equipment market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period (2023-2030). To encourage quick recovery after procedures, patients are now choosing to avoid invasive surgeries, and even doctors are choosing approaches that result in little incisions. Neonatal jaundice results from elevated total serum bilirubin (TSB) and clinically manifests as yellowish discoloration of the skin, sclera, and mucous membrane. In most cases, it is a mild, transient, and self-limiting condition and is referred to as "physiological Jaundice." Failure to identify and treat this entity may result in bilirubin encephalopathy and associated neurological sequelae. Approximately 60% of term and 80% of preterm newborns develop clinical jaundice in the first week after birth. In newborns, unconjugated hyperbilirubinemia is very common, and increased bilirubin levels can cause life-threatening kernicterus.
Browse the full report description of “Phototherapy Equipment Market Size, Share & Trends Analysis Report by Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, and Fiber Optic Phototherapy Equipment), by Application (Skin Disease Treatment and Neonatal Jaundice Management), and by End-user (Hospitals, Clinics and Homecare), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/phototherapy-equipment-market
The standard of care for treating pathological unconjugated hyperbilirubinemia is still phototherapy. The necessity for exchange transfusions and the risk of bilirubin toxicity are both decreased by phototherapy, which is particularly successful at lowering TSB to safe levels. It is a treatment with a special type of light which is used to treat newborn jaundice by making it easier for your baby's liver to break down and remove the bilirubin from the baby's blood. Phototherapy aims to expose a baby's skin to as much light as possible. During PT newborns are placed under a light either in a cot or incubator with their eyes covered. Latest technological advancements have made it easy for parents to treat mild jaundice at home by using “bili lights” or “bili-blankets” to reduce jaundice. For instance, In February 2019, G.E. Healthcare announced a new phototherapy system named BiliSoft 2.0 for infants with jaundice. It is used to treat hyperbilirubinemia and offers quality care. The long-lasting, high–spectral–irradiance, blue LED light delivers healing phototherapy. Positioning aids may also be placed under the pad to bring more light to the sides of a baby’s body for greater skin surface area exposure to the light.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Phoenix Medical Systems, Natus Medical Incorporated., Alfamedic s. r. o. and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Phototherapy Equipment Market Report Segment
By Product
By Application
• Skin Disease Treatment
o Mycosis fungicides
o Psoriasis
o Vitiligo
o Others (Eczema, Morphea)
• Neonatal Jaundice Management
By End-User
Global Phototherapy Equipment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/phototherapy-equipment-market